What are the most likely complications of hyperthermia in a pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Likely Complications of Hyperthermia in Pediatric Patients

The most likely complications of severe hyperthermia in pediatric patients are central nervous system dysfunction (including seizures, delirium, coma, and permanent brain damage), multi-organ failure (affecting the heart, liver, kidneys, and muscles), rhabdomyolysis with acute renal failure from myoglobinuria, circulatory collapse, and death.

Central Nervous System Complications

CNS abnormalities represent the most prominent and serious complications in pediatric hyperthermia. When core body temperature reaches ≥40°C (104°F), children are at high risk for delirium, convulsions, and coma 1. The severity escalates rapidly with sustained hyperthermia:

  • Seizures and encephalopathy: Severe electroencephalographic abnormalities can occur even with aggressive anticonvulsant therapy, potentially leading to diffuse cerebral cortical damage 2. Hyperthermia damages the CNS by causing increased intracranial pressure and cerebral edema, triggering severe neuronal excitation 2.

  • Permanent neurological sequelae: Case reports document severe mental retardation, hypertonia, and quadriplegia following pediatric hyperthermia episodes 2. The younger the child, the more vulnerable they appear to be to these complications.

  • Altered mental status: Confusion, somnolence, and delirium are common presenting features 3.

Multi-Organ Dysfunction

Hyperthermia induces profound damage to multiple organ systems simultaneously 1:

Cardiovascular System

  • Circulatory failure and inability to maintain adequate cardiac output 1
  • Tachycardia and arrhythmias 3, 4
  • Potential cardiac arrest with severe hyperkalemia 4

Renal System

  • Rhabdomyolysis with myoglobinuria is a critical complication that can rapidly progress to tubular necrosis and acute renal failure 3. Dark red or cola-colored urine is a warning sign 3, 4.
  • Elevated serum creatine kinase levels can reach extraordinarily high values (>178,000 IU/L documented) 3

Hepatic System

  • Marked elevation of liver enzymes (AST >4,000 IU/L, ALT >1,000 IU/L) 3
  • Hepatic dysfunction as part of multi-organ failure 1

Musculoskeletal System

  • Muscle rigidity and painful sensitivity 3
  • Severe rhabdomyolysis with massive enzyme release 3, 4

Metabolic Derangements

  • Severe metabolic and respiratory acidosis develops rapidly 3, 4
  • Hyperkalemia with potential for tented T-waves on ECG 4
  • Endotoxemia 1

Mortality Risk

The mortality rate remains significant despite modern treatment. In malignant hyperthermia specifically, UK data shows approximately 4% mortality 5, while historical data in general pediatric hyperthermia (temperature ≥41.1°C) documented a 3.8% death rate 6. Serious illness occurs in approximately 62% of children with hyperthermia ≥41.1°C 6.

Age-Specific Vulnerabilities

Pediatric patients, particularly those ≤5 years old, face substantially higher risk 7. The highest incidence of complications occurs in the youngest children 5, 2. Factors that increase complication risk include:

  • Age ≤5 years (OR 3.5) 7
  • Severe craniocerebral injury (OR 6.4) 7
  • Elevated intracranial pressure ≥20 mmHg (OR 4.6) 7
  • Pulmonary infection (OR 5.4) 7
  • MRSA infection (OR 3.1) 7

Critical Pitfalls to Avoid

Temperature-control dysregulation can persist even after initial cooling, leading to recurrent hyperthermia 1. Delayed recognition dramatically worsens outcomes—organ and tissue damage occurs when signs are not promptly recognized and rapidly cooled 1.

In malignant hyperthermia cases, previous uneventful anesthetics do not exclude MH susceptibility—patients can receive multiple normal anesthetics before triggering 5. This false reassurance can delay diagnosis and treatment.

Pneumonia is the most common underlying serious illness in pediatric hyperthermia (36% of cases), followed by bacteremia (6.7%) and bacterial meningitis (5.7%) 6. However, the hyperthermia itself—not just the underlying cause—drives the complications described above.

Related Questions

Besides halogenated inhalational anesthetics and succinylcholine, what other medications can trigger malignant hyperthermia during anesthesia for a laparoscopic cholecystectomy?
What are the possible causes of overheating (hyperthermia) of the body?
How many vials of dantrolene sodium are needed to manage malignant hyperthermia in a 70‑kg patient undergoing anesthesia?
What is the drug of choice for malignant hyperthermia?
In a 22-year-old man with a history of lithium, quetiapine, and fluoxetine use who develops malignant hyperthermia after succinylcholine administration, presenting with fever, tachycardia, hypotension, diffuse muscular rigidity, rising end‑tidal CO₂, elevated plateau pressures, and severe respiratory acidosis, what is the next best treatment?
What is the quality of the evidence supporting the recommendation against routine furosemide administration after a single unit of packed red blood cells in a hemodynamically stable adult?
What is the appropriate management for a 36‑year‑old adult with a one‑week history of odontogenic pain that progressed to severe odynophagia, fever, trismus, and submental edema?
What is the recommended management for congenital aortic and pulmonary stenosis?
For a Caucasian patient currently on a single‑pill triple antihypertensive (e.g., valsartan 160 mg/amlodipine 10 mg/chlorthalidone 25 mg), does ethnicity require any change in the treatment regimen?
What is the appropriate management for a 55-year-old male with persistent left lower quadrant abdominal pain, prior diverticulitis, recent melena while on antibiotics, a negative Cologuard test, and a low‑fiber diet?
What is a cheaper alternative to pimecrolimus (Protopic) for treating vulvar dermatitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.